Improved biomarkers for prostate cancer: a definite need.
Carter
H Ballentine
HB
Isaacs
William B
WB
D014408:Biomarkers, Tumor / Q000097:blood*; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D008040:Genetic Linkage; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000706:statistics & numerical data; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood* / Q000201:enzymology / Q000276:immunology / Q000401:mortality; D019998:Racemases and Epimerases / Q000097:blood / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D012680:Sensitivity and Specificity; D015854:Up-Regulation
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen; D019998:Racemases and Epimerases; C108352:alpha-methylacyl-CoA racemase